Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Female-headed households more prone to economic strains due to rainfall variations
2016-02-02

Description: Martin Flatø  Tags: Martin Flatø

Martin Flatø
Photo: University of Oslo press

Research shows that a total of 41 % of South African (SA) households are led by women, and these households are twice as likely to be poor compared to other households.

Martin Flatø spent three months at University of the Free State (UFS), researching how female-headed households in our country are affected by variations in rainfall, which cause crop failures with their implications for rural economies.

He is a PhD student from the University of Oslo in Norway who was part of the 2014/15 Southern African Young Scientists Summer Programme (SA-YSSP) that was hosted by the UFS last year.

Flatø formed part of a group of international scholars who conducted research on how families led by females are affected by climate change. The group focused on the implications of the weather on crop failures and rural economies. Gender and household structures were studied to determine ways in which they are affected by economic fluctuations.
 
The research group’s preliminary findings indicate that female-headed households are more vulnerable to rainfall variation than households where there are adult residents or workers of both genders.

In view of the current water shortage in the Free State, as well as scientists’ projections that our country will be among the regions hardest hit by climate change in terms of a surge in temperature, Flatø’s collaborative research has substantial relevance.|

Grooming first class scientists
The SA-YSSP is a joint initiative of South African National Research Foundation and the International Institute of Applied Systems Analysis (IIASA). Its main aim is tackling challenges faced by the world at large and South Africa in particular.

Out of 24 PhD students from 18 countries and various academic disciplines, Flatø emerged as one of only three scholars to be awarded the Systems Analysis Scholarships for his outstanding science at the end of the programme.

World class mentorship
Prof André Pelser and Dr Raya Muttarak were Flatø’s SA-YSSP supervisors. Prof Pelser, of the UFS Department of Sociology, is a leading academic on population processes, and how they relate to local environmental issues in South Africa. Dr Muttarak is a research scholar at IIASA in Austria.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept